These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 21901368)

  • 1. Increased d-dimer levels predict cardiovascular mortality in patients with systolic heart failure.
    Zorlu A; Yilmaz MB; Yucel H; Bektasoglu G; Refiker Ege M; Tandogan I
    J Thromb Thrombolysis; 2012 May; 33(4):322-8. PubMed ID: 21901368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between D-dimer level and the development of atrial fibrillation in patients with systolic heart failure.
    Zorlu A; Akkaya E; Altay H; Bektasoglu G; Turkdogan KA; Sincer I; Vuruskan E; Cınar Z; Tandogan I; Yilmaz MB
    J Thromb Thrombolysis; 2012 May; 33(4):343-8. PubMed ID: 22139027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated D-dimer levels predict adverse outcomes in hospitalised elderly patients with chronic heart failure.
    Yan W; Liu J; Liu H; Lu J; Chen J; Rong R; Song L; Tang H; Li J; He K
    Intern Med J; 2019 Oct; 49(10):1299-1306. PubMed ID: 30985051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment.
    Lip GY; Lowe GD; Rumley A; Dunn FG
    Br Heart J; 1995 Jun; 73(6):527-33. PubMed ID: 7626351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular mortality and chronotropic incompetence in systolic heart failure: the importance of a reappraisal of current cut-off criteria.
    Magrì D; Corrà U; Di Lenarda A; Cattadori G; Maruotti A; Iorio A; Mezzani A; Giannuzzi P; Mantegazza V; Gondoni E; Sinagra G; Piepoli MF; Fiorentini C; Agostoni P
    Eur J Heart Fail; 2014 Feb; 16(2):201-9. PubMed ID: 24464973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of plasma galectin-3 levels in systolic heart failure to predict renal insufficiency and survival.
    Tang WH; Shrestha K; Shao Z; Borowski AG; Troughton RW; Thomas JD; Klein AL
    Am J Cardiol; 2011 Aug; 108(3):385-90. PubMed ID: 21600537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conductive channels identified with contrast-enhanced MR imaging predict ventricular tachycardia in systolic heart failure.
    Lin LY; Su MY; Chen JJ; Lai LP; Hwang JJ; Tseng CD; Chen YS; Yu HY; Tseng WY; Lin JL
    JACC Cardiovasc Imaging; 2013 Nov; 6(11):1152-9. PubMed ID: 24229767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma D-dimer concentrations predicting stroke risk and rivaroxaban benefit in patients with heart failure and sinus rhythm: an analysis from the COMMANDER-HF trial.
    Ferreira JP; Lam CSP; Anker SD; Mehra MR; van Veldhuisen DJ; Byra WM; La Police DA; Cleland JGF; Greenberg B; Zannad F
    Eur J Heart Fail; 2021 Apr; 23(4):648-656. PubMed ID: 32959502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic role of D-dimer for in-hospital and 1-year mortality in exacerbations of COPD.
    Hu G; Wu Y; Zhou Y; Wu Z; Wei L; Li Y; Peng G; Liang W; Ran P
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2729-2736. PubMed ID: 27843309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic role of soluble suppression of tumorigenicity-2 on cardiovascular mortality in outpatients with heart failure.
    Gül İ; Yücel O; Zararsız A; Demirpençe Ö; Yücel H; Zorlu A; Yılmaz MB
    Anatol J Cardiol; 2017 Sep; 18(3):200-205. PubMed ID: 28761021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Markers of hypercoagulability and inflammation predict mortality in patients with heart failure.
    Marcucci R; Gori AM; Giannotti F; Baldi M; Verdiani V; Del Pace S; Nozzoli C; Abbate R
    J Thromb Haemost; 2006 May; 4(5):1017-22. PubMed ID: 16689753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High D-dimer levels predict cardiovascular events in patients with chronic atrial fibrillation during oral anticoagulant therapy.
    Vene N; Mavri A; Kosmelj K; Stegnar M
    Thromb Haemost; 2003 Dec; 90(6):1163-72. PubMed ID: 14652652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The product of eGFR and hemoglobin may help predict mortality in systolic heart failure patients without severe anemia and renal failure.
    Yılmaz MB; Zorlu A; Bektaşoğlu G; Yontar OC; Tandoğan I
    Turk Kardiyol Dern Ars; 2012 Jan; 40(1):9-15. PubMed ID: 22395368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between plasma (D)-dimer level and cerebral infarction volume in patients with nonvalvular atrial fibrillation.
    Matsumoto M; Sakaguchi M; Okazaki S; Furukado S; Tagaya M; Etani H; Shimazu T; Yoshimine T; Mochizuki H; Kitagawa K
    Cerebrovasc Dis; 2013; 35(1):64-72. PubMed ID: 23428999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of outcome by highly sensitive troponin T in outpatients with chronic systolic left ventricular heart failure.
    Egstrup M; Schou M; Tuxen CD; Kistorp CN; Hildebrandt PR; Gustafsson F; Faber J; Goetze JP; Gustafsson I
    Am J Cardiol; 2012 Aug; 110(4):552-7. PubMed ID: 22579083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation of bundle branch block to long-term (four-year) mortality in hospitalized patients with systolic heart failure.
    Barsheshet A; Goldenberg I; Garty M; Gottlieb S; Sandach A; Laish-Farkash A; Eldar M; Glikson M
    Am J Cardiol; 2011 Feb; 107(4):540-4. PubMed ID: 21184999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of pulse-wave tissue Doppler parameters in patients with systolic heart failure.
    Olson JM; Samad BA; Alam M
    Am J Cardiol; 2008 Sep; 102(6):722-5. PubMed ID: 18773996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of atrial fibrillation on plasma von willebrand factor, soluble E-selectin, and N-terminal pro B-type natriuretic peptide levels in systolic heart failure.
    Freestone B; Gustafsson F; Chong AY; Corell P; Kistorp C; Hildebrandt P; Lip GY
    Chest; 2008 May; 133(5):1203-8. PubMed ID: 18339785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Top ten risk factors for morbidity and mortality in patients with chronic systolic heart failure and elevated heart rate: The SHIFT Risk Model.
    Ford I; Robertson M; Komajda M; Böhm M; Borer JS; Tavazzi L; Swedberg K;
    Int J Cardiol; 2015 Apr; 184():163-169. PubMed ID: 25703424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of heart rate in elderly with systolic heart failure and concomitant atrial fibrillation.
    Barywani S; Petzold M
    Scand Cardiovasc J; 2017 Aug; 51(4):190-196. PubMed ID: 28393567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.